Impact of Artificial Intelligence-Enhanced Optical Coherence Tomography Software on Percutaneous Coronary Intervention Decisions

人工智能增强型光学相干断层扫描软件对经皮冠状动脉介入治疗决策的影响

阅读:1

Abstract

BACKGROUND: Integration of intravascular imaging into percutaneous coronary intervention (PCI) workflow demands physician time and expertise. Artificial intelligence (AI)-enabled software that automates the identification of key intravascular imaging parameters has the potential to streamline physician workflow, increase accuracy, and reduce variability in PCI planning decisions. This study investigated if AI-enabled software, Ultreon (Abbott), compared with traditional software, AptiVue (Abbott), improved physician decision-making accuracy, variability, and efficiency in optical coherence tomography (OCT)-based PCI planning. METHODS: In this multireader, multicase study, 30 interventional cardiologists of varying OCT imaging experience evaluated 21 pre-PCI OCT pullbacks using both Ultreon and AptiVue platforms. Physician PCI planning decisions about lesion morphology, length, and diameter were compared to published best practices. Decision accuracy, variability, and time efficiency were assessed using statistical models. RESULTS: Physician OCT-based planning decisions were more accurate using Ultreon compared to AptiVue in the identification of calcium severity by 1.77 (95% CI, 1.27-2.50; P < .001), vessel preparation strategy by 2.00 (95% CI, 1.12-3.4; P = .018), and stent diameter by 2.83 (95% CI, 1.79-4.50; P < .001). Physicians exhibited less variability in assessments using Ultreon, especially for distal and proximal stent landing zone, and planned stent length (P < .0001). The efficiency of OCT assessments was improved with Ultreon, reducing the duration of OCT assessments by 0.5 minutes (P < .0001). The benefits were observed irrespective of the physician's prior OCT experience. CONCLUSIONS: Physician OCT-based PCI planning decisions were more accurate, less variable, and more efficient with AI-enhanced Ultreon software. This could potentially aid in the fuller adoption of intravascular imaging in PCI workflow.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。